Abstract:<section class="article-section__content"><h3 class="article-section__sub-title section1"> Purpose</h3><p>Deuterium metabolic imaging (DMI) maps the uptake of deuterated precursors and their conversion into lactate and other markers of tumor metabolism. Even after leveraging <sup>2</sup>H's short T<sub>1</sub>s, DMI's signal-to-noise ratio (SNR) is limited. We hypothesize that a multi-echo balanced steady-state free precession (ME-bSSFP) approach would increase SNR compared to chemical shift imaging (CSI), while achieving spectral isolation of the metabolic precursors and products. </p></section><section class="article-section__content"><h3 class="article-section__sub-title section1"> Methods</h3><p>Suitably tuned <sup>2</sup>H ME-bSSFP (five echo times [TEs], ΔTE = 2.2 ms, repetition time [TR]/flip-angle = 12 ms/60°) was implemented at 15.2T and compared to CSI (TR/flip-angle = 95 ms/90°) regarding SNR and spectral isolation, in simulations, in deuterated phantoms and for the in vivo diagnosis of a mouse tumor model of pancreatic adenocarcinoma (N = 10). </p></section><section class="article-section__content"><h3 class="article-section__sub-title section1"> Results</h3><p>Simulations predicted an SNR increase vs. CSI of 3-5, and that the peaks of <sup>2</sup>H-water, <sup>2</sup>H<sub>6,6'</sub>-glucose, and <sup>2</sup>H<sub>3,3'</sub>-lactate can be well isolated by ME-bSSFP; phantoms confirmed this. In vivo, at equal spatial resolution (1.25 × 1.25 mm<sup>2</sup>) and scan time (10 min), <sup>2</sup>H<sub>6,6'</sub>-glucose's and <sup>2</sup>H<sub>3,3'</sub>-lactate's SNR were indeed higher for bSSFP than for CSI, three-fold for glucose (57 ± 30 vs. 19 ± 11, <i>P</i> < .001), doubled for water (13 ± 5 vs. 7 ± 3, <i>P</i> = .005). The time courses and overall localization of all metabolites agreed well, comparing CSI against ME-bSSFP. However, a clearer localization of glucose in kidneys and bladder, the detection of glucose-avid rims in certain tumors, and a heterogeneous pattern of intra-tumor lactate production could only be observed using ME-bSSFP's higher resolution. </p></section><section class="article-section__content"><h3 class="article-section__sub-title section1"> Conclusions</h3><p>ME-bSSFP provides greater SNR per unit time than CSI, providing for higher spatial resolution mapping of glucose uptake and lactate production in tumors.</p></section>

A Metabolite Specific 3D Stack-of-spirals Bssfp Sequence for Improved Bicarbonate Imaging in Hyperpolarized [1-13C]pyruvate MRI

A Metabolite Specific 3D Stack-of-Spiral bSSFP Sequence for Improved Lactate Imaging in Hyperpolarized [1-$^{13}$C]Pyruvate Studies on a 3T Clinical Scanner

Rotated spiral RARE for high spatial and temporal resolution volumetric arterial spin labeling acquisition

Rapid 3D Dynamic Arterial Spin Labeling with a Sparse Model-Based Image Reconstruction

Feasibility of Balanced Steady-State Free Precession Sequence at 1.5T for the Evaluation of Hepatic Steatosis in Obese Children and Adolescents

3D Golden Angle Stack-of-Spiral Bssfp Sequence for Undersampled Lactate Imaging in Hyperpolarized MRI

Multi-band echo-planar spectroscopic imaging of hyperpolarized 13 C probes in a compact preclinical PET/MR scanner

A pharmacokinetic model for hyperpolarized 13C‐pyruvate MRI when using metabolite‐specific bSSFP sequences

Improved reconstruction stability for chemical shift encoded hyperpolarized 13 C magnetic resonance spectroscopic imaging using k-t spiral acquisitions

Translation of Carbon-13 EPI for hyperpolarized MR molecular imaging of prostate and brain cancer patients

In vivo Metabolic Sensing of Hyperpolarized [1‐13 C]Pyruvate in Mice Using a Recyclable Perfluorinated Iridium Signal Amplification by Reversible Exchange Catalyst

A Regional Bolus Tracking and Real-time B$_1$ Calibration Method for Hyperpolarized $^{13}$C MRI

Mapping Pyruvate-to-Lactate Rate Constants in Hyperpolarized Data with Bssfp Acquisitions

Enhanced hyperpolarized chemical shift imaging based on a priori segmented information

Hyperpolarized 13 C MRI : State of the Art and Future Directions

Hyperpolarized [2- 13 C]Pyruvate MR Molecular Imaging with Whole Brain Coverage

Protocol for producing hyperpolarized 13C-bicarbonate for clinical MRI of extracellular pH in aggressive tumors

First in‐human evaluation of [1‐13C]pyruvate in D2O for hyperpolarized MRI of the brain: A safety and feasibility study

Hyperpolarized 13C metabolic imaging of the human abdomen with spatiotemporal denoising

Improving deuterium metabolic imaging (DMI) signal‐to‐noise ratio by spectroscopic multi‐echo bSSFP: A pancreatic cancer investigation

13C MRI of hyperpolarized pyruvate at 120 μT